Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 27 2022

Full Issue

Menthol Vapes Don't Help People Quit Smoking, FDA Says

The FDA said Logic Technology Development had not shown its menthol products were more likely than non-flavored ones to help people quit smoking, and also said the products risked enticing young people. An epilepsy treatment, OptumRx, and more are in the news.

USA Today: FDA Rejects Menthol Flavored E-Cigarettes In Latest Vaping Knock-Down, Cites Harm To Youth

The FDA said Logic Technology Development didn't show its menthol products are more likely than non-flavored products to help people quit or reduce smoking. Combined with the risk of enticing youth vapers who like menthol vapes, the agency rejected the company's marketing of Logic Pro and Logic Power menthol e-liquid packages. (Alltucker, 10/26)

In other pharmaceutical news —

The New York Times: Gene Treatment For Rare Epilepsy Causes Brain Side Effect In 2 Children 

Weeks after Valeria Schenkel took an experimental drug named after her, the daily seizures that had afflicted her from birth became less frequent. But the drug caused fluid to build up in her brain, and a year later, she died at age 3. The drug was given to only one other child, and she experienced the same side effect and nearly died last year. (Hayden, 10/26)

Fierce Healthcare: Health Tech Startup Ixlayer Partners With CVS Health On Home Tests

Initial home sample collection kits will target vitamin D, Lyme disease, sexually transmitted infections and thyroid function with a plan to expand early next year, executives told Fierce Healthcare. In addition to the kits, users will have access to a platform that transmits test results and resources for understanding them. (Gliadkovskaya, 10/26)

Columbus Dispatch: OptumRx To Pay Ohio $15 Million To Settle Suit. The PBM Denies Such

"We have not reached a final agreement with the Ohio Attorney General. We continue to dispute his allegations and are honored to have delivered access to more affordable prescription medications for the Ohio Bureau of Workers’ Compensation and Ohio taxpayers,” said Andrew Krejci, spokesperson for the company. (Wu, 10/26)

CNBC: How Organ Donation Works In The United States

There are more than 100,000 people in the United States waiting for an organ transplant, according to the United Network for Organ Sharing, known as UNOS. (Morabito, 10/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF